Pure Global AI
ANVISA registration 81905510032Valid until Apr 25, 2032

HERPES VIRUS (HHV 2)

ANVISA Registration Number: 81905510032GMRB COMÉRCIO DE PRODUTOS MÉDICOS E DIAGNÓSTICOS LTDANOVATEC IMMUNDIAGNOSTICA GMBHRisk Class III
Device names
Technical name
HERPES VIRUS (HHV 2)
PT: HERPES VÍRUS (HHV 2)
Commercial name
NovaLisa® Herpes simplex Virus 2 (HSV 2) IgG
Risk class
Class III
Registration details
Registration Number
81905510032
Process Number
25351527138202135
CNPJ
34255136000164
Company information
Manufacturing Country
Germany
PT: ALEMANHA
Dates and status
Publication Date
Apr 25, 2022
Validity
25/04/2032
Last Updated
08/18/2026 19:00:00
About this record

Access comprehensive regulatory information for HERPES VIRUS (HHV 2) in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 81905510032 and manufactured by NOVATEC IMMUNDIAGNOSTICA GMBH. The registration is held by GMRB COMÉRCIO DE PRODUTOS MÉDICOS E DIAGNÓSTICOS LTDA with validity until Apr 25, 2032.

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.